Timing of radiotherapy in the treatment of breast cancer. A review of the literature;Timing della radioterapia nel trattamento del carcinoma mammario. Revisione della letteratura

Annali Italiani di Chirurgia

Volumn 70, Issue 3, 1999, Pages 371-376

  Trovo M G ^a   Gigante, M ^a   Roncadin, M ^a   Arcicasa, M ^a   Bortolus, R ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Breast cancer; Radiotherapy; Timing

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BREAST RECONSTRUCTION; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MORTALITY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; REVIEW; TIME;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAMMAPLASTY; POSTOPERATIVE CARE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0033125504     PISSN: 2239253X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Berrino P., Campora E., Santi P.: Postquadrantectomy breast deformity: Classification and techniques of surgical correction. Hast Reconstr Surg, 79:567-72, 1987.
2. Berrino P., Campora E., Santi P.: Reconstruction of the radiated partial mastectomy defect with autogenous tissues. Plast Reconstr Surg. 92: 380-1, 1993.
3. Bucholz T.A., Austin-Seymour M.M., Moe R.E., Ellis G.K., Livingston R.B., Pelton J.G., Griffin T.W.: Effect of delay in radiation iti the combined modality treatment of breast cancer. Int J Radiar Oncol Biol Phys, 26:23-35, 1993.
4. Burk R.W., Grotting J.C.: Conceptual considerations in breast reconstruciton. Clin Plastic Surg, 22:141-52, 1995.
5. Buzdar A.U., Wan Kau S., Smith T.L., Ames F., Singletary E-. Strom E., McNeese M., Hortobagyi G.N.: The order of administration of chemotherapy and radiation and its effect on the local control of operable breast cancer. Cancer, 71:3680-84, 1993.
6. Buzzoni R., Bonadonna G., Valagussa P., Zambetti M.: Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. J Clin Oncol, 9: 2134, 1991.
7. Evans G.R., Schusterman M.A., Kroll S.S., Miller M.J., Riece G.P., Robb G.L., Ainslie N.: Reconstruction and the radiated breast: is there a role for implant? Plast Reconstr Surg, 96:1111-5, 1995.
8. Franceschi S., Bidoli E., Prati S., Fascioli S., Redivo A.: Andamento della mortalità per tumore e per altre cause in Friuli-Venezia Giulia e in Italia. Trends of cancer and non cancer mortality in Friuli-Venezia Giulia and in Italy, 1970-1989. Centro di Riferimento Oncologico, Aviano, 1994.
9. Hartsell W., Recine D., Griem K.: Does delay in the initiation of radiation therapy adversely affect local control in treatment of intact breast Radiother Oncol, 24:37, 1992.
10. Harrington K.J., Harrison M., Bayle P., Evans K., Dunn P.A., Lambert H.E., Saidan Z., Lynn J., Stewart J.S.: Surgical clips in planning the electron boost in breast cancer: a qualitative and quantitative evaluation. Int J Radiat Oncol Biol Phys, 34:579-84, 1996.
11. Hunt K.K., Baldwin B.J., Strom E.A., Ames F.C., McNeese M.D., Kroll S.S., Singletary S.E.: Feasibility of postmastectomy radiation therapy afier TRAM flap breast reconstruction. Ann Surg Oncol, 4:377-384, 1997.
12. Kelsey J.L.: A review of the epidemiology of human breast cancer. Epidemiol Rev, 1:74-109, 1979.
13. Kraemer O., Andersen M., Siim E.: Breast reconstruction and tissue expansion in irradiated versus not irradiated women after mastectomy. Scand J Plast Reconstr Surg Hand Surg, 30:201(6), 1996.
14. Kurul S., Dincer M., Kizir A., Uzunismail A., Darendeliler E.: Plastic surgery in irradiated areas: analysis of 200 consecutive cases. Eur J Surg Oncol, 23 :48-53, 1997.
15. th Annual Meeting A.S.T.R.O., Orlando, Florida (U.S.A.), # 110, 1997.
16. Kuske R.R., Schuster R., Klein E., Young L., Perez C.A., Fineberg B.: Radiotherapy and breast reconstruction: clinical results and dosimetry. Int J Radiat Oncol Biol Phys, 21:339-346, 1991.
17. Lara Jimenez P., Garcia Puche J., Pedraza V.: Adjuvant combined modality treatment in high risk breast cancer patients: ten years results. Proc. 5th EORTC Breast Cancer Working Conference A293, 1991.
18. Goldhirsch A., Davis B., Bettelheim R., Hartmann W., Castiglione M., Pedrazzini A., Zava D., Wiedmer C., Gelber R.D., Stanley K.: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med, 320:491-6, 1989.
19. Margolese R.: Surgical consideration in selecting local therapy. J Natl Cancer Inst Monogr, 11: 41, 1992.
20. Markiewicz D., Schultz D., Haas J: The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conserving surgery and radiation therapy in stage I and II breast cancer. Annual Meeting of the American Society of Radiology and Oncology, 149, 1995.
21. McCormick B., Begg C., Norton I. et al.: Timing of radiotherapy in the treatment of early stage breast cancer. J Clin Oncol, 11:191-3, 1993.
22. McCormick B., Hakes T., Yahalom J., Kinne D., Norton L.: Breast conserving surgery and radiation: the delay of primary radiation after adjuvant chemotherapy does not influence local control. Am J Clin Oncol, 11:55, # 47, 1992.
23. Meek A., Order S., Abeloff M. et al.: Concurrent radioche-motherapy in advanced breast cancer. Cancer, 51:1001, 1983.
24. Moro G., Stasi M., Casanova Borea V.: Does concomitant che-moradiotherapy influence cosmetic outcome in conservative treatment of breast cancer? Tumori, 83:743-747, 1997.
25. Nixon A.J., Recht A., Neuberg D., Connolly J.L., Schnitt S., Abner A., Harris J.R.: The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with brea-st-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys, 30:17-21, 1994.
26. Nixon A.J., Troyan S.L., Harris J.R.: Options in the local management of invasive breast cancer. Semin Oncol, 23:453-463, 1996.
27. Nixon A.J., Manola J., Gelman R., Bornstein B., Abner A., Hetelakidis S., Recht A., Harris J.R.: No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol, 16:1374-9, 1998.
28. Overgaard M., Hansen P.S., Overgaard J., Rose C., Andersson M., Bach F., Kjaer M., Gadeberg C.C., Mouridsen H.T., Jensen M.B., Zedeler K.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjttvant chemotherapy. N Engl J Med, 337:949-55, 1997.
29. Petit J.Y., Lehman A.: Role of plastic surgery in the treatment of breast cancer. Bull Acad Natl Med, 180:317-28, 1996.
30. Recht A., Come S.E., Gelman R.S., Goldstein M., Tishler S., Gore S.M., Abner A.L., Vicini F.A., Silver B., Connolly J.L., Schnitt S.J., Coleman C.N., Harris J.R.: Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing and outcome. J Clin Oncol, 9:1662-67, 1991.
31. Recht A., Come S.E., Silver B., Gelman R.S., Hayers D.F., Shulman L.N., Henderson I.C., Harris J.R.: Sequencing of chemotherapy (CT) and radiotherapy (RT) following conservative surgery (CS) for patients with early-stage breast cancer: results of a randomized trial. Int J Radiat Oncol Biol Phys, 32:148, # 14, 1995.
32. Sarkaria J., Miller E., Parker C.: 4-hydroxytamoxifen, an active metabolite of tamoxifen, does not alter the radiation sensitivity of MCF-7 breast carcinoma celb irradiated in vitro. Breast Cancer Res Treat, 30:159-65, 1994.
33. Schuster R.H., Kuske R.R., Young V.L., Fineberg B.: Breast reconstruction in women treated with radiation therapy for breast cancer: cosmesis, complications, and tumor control. Plastic Reconstrsuct Surg, 90:445-452, 1992.
34. Slotman B.J., Meyer O.W.M., Njo K.H., Karim A.B.M.F.: Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol, 30:206-212, 1994.
35. Styblo T.M., Lewis M.M., Carlson G.W., Murray D.R., Wood W.C., Lawson D., Landry J., Hughes L., Nahai F., Bostwick J.: Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap. Ann Surg Oncol, 3:375-80, 1996.
36. von Smitten K., Sundell B.: The impact of adjuvant radiotherapy and cytotoxic chemotherapy on the outcome of immediate breast reconstruction by tissue expansion after mastectomy for breast cancer. Eur J Surg Oncol, 18:119-23, 1992.
37. Wallgren A., Bernier J., Gelber R.D., Goldhirsch A., Roncadin M., Joseph D., Castiglione-Gertsch M. for the International Breast Cancer Study Group: Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys, 35:649-659, 1996.
38. Wazer D., Joyce M., Chan W. et al.: Effects of tamoxifen on the radiosensitivity of hormonally responsive and unresponsive breast carcinoma cells. Radiat Oncol Invest, 1:20, 1993.
39. Williams J.K., Bostwick J. 3rd, Bried J.T., Mackay G., Landry J., Benton J.: TRAM flap breast reconstruction after radiation treatment. Ann Surg, 221:756-64, 1995.
40. Williams J.K., Carlson G.W., Bostwick J. 3rd, Bried J.T., Mackay G.: The effects of radiation treatment after TRAM flap breast reconstruction. Plast Reconstr Surg, 100:1153-60, 1997.
41. Wurschmidt F., Willers H., Janik I., Bunemann H., Heilmann H.P.: Combined breast conserving surgery, chemotherapy, and irradiation in breast cancer treatment: Role of the interval between surgery and onset of radiotherapy. Strahlenther Onkol, 173:148-154, 1997.